$6.5 billion acquisition: Deutsche Bank AG, Eli Lilly & Co, ImClone Systems Inc, JP Morgan & Co, UBS Investment Bank - International Law Office - Deal Information
Deal Details
$6.5 billion acquisition Deutsche Bank AG, Eli Lilly & Co, ImClone Systems Inc, JP Morgan & Co, UBS Investment Bank
Eli Lilly & Co has agreed to acquire ImClone Systems Inc for a total consideration of $6.5 billion. The transaction is subject to a majority of the outstanding ImClone shares being tendered, as well as other regulatory approvals.
JP Morgan & Co acted as financial adviser to ImClone. UBS Investment Bank and Deutsche Bank AG acted as financial advisers to Eli Lilly.
Value: $6.5 billion
Announced: October 06 2008
| Parties involved | Legal advisers |
|---|---|
|
Deutsche Bank AG (Banks) Financial adviser to acquirer |
|
|
Eli Lilly & Co (Food & Drug Retailers) Acquirer |
Latham & Watkins - Menlo Park
Latham & Watkins LLP - New York NY M Adel Aslani-Far |
|
ImClone Systems Inc (Pharmaceuticals) Target |
|
|
JP Morgan & Co (Speciality & Other Finance) Financial adviser to target |
Davis Polk & Wardwell LLP - New York NY
Phillip R Mills |
|
UBS Investment Bank (Speciality & Other Finance) Financial adviser to acquirer |
